SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (709)6/30/2003 3:58:59 PM
From: Icebrg  Respond to of 2240
 
Wilder

No, I am not are of that. There is a fight going on on the other (agonist-) side.

I am normally not too concerned with potentially competitive patents. If things go bad they may end up in court and then have to pay a minor license fee. It's not like something going generic. But it may be worthwhile to look into. I will ask the guys over at Yahoo, if they know anything.

Erik



To: keokalani'nui who wrote (709)7/25/2003 5:28:14 PM
From: keokalani'nui  Read Replies (1) | Respond to of 2240
 
Parking. PFE 2003 App #20030086930 claims human anti-ctla-4 for anti-cancer purposes; with imcl-like "in combination" with specific anti-neoplastic agents. Recites Allison prior art disingenously: "U.S. Pat. No. 5,811,097 of Allison et al. refers to administration of CTLA-4 blocking agents to decrease tumor cell growth."


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News